Cargando…
Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma
BACKGROUND: CD86 has great potential to be a new target of immunotherapy by regulating cancer immune response. However, it remains unclear whether CD86 is a friend or foe in lower-grade glioma (LGG). METHODS: The prognostic value of CD86 expression in pan-cancer was analyzed using Cox regression and...
Autores principales: | Qiu, Huaide, Tian, Wei, He, Yikang, Li, Jiahui, He, Chuan, Li, Yongqiang, Liu, Ning, Li, Jianan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089378/ https://www.ncbi.nlm.nih.gov/pubmed/33954112 http://dx.doi.org/10.3389/fonc.2021.654350 |
Ejemplares similares
-
A Prognostic Microenvironment-Related Immune Signature via ESTIMATE (PROMISE Model) Predicts Overall Survival of Patients With Glioma
por: Qiu, Huaide, et al.
Publicado: (2020) -
Prognostic Value of an Autophagy-Related Five-Gene Signature for Lower-Grade Glioma Patients
por: Guo, Jin-Cheng, et al.
Publicado: (2021) -
WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas
por: Carstam, Louise, et al.
Publicado: (2022) -
Prognostic and Predictive Value of Immune-Related Gene Pair Signature in Primary Lower-Grade Glioma Patients
por: Lei, Kunjian, et al.
Publicado: (2021) -
A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients
por: He, Yikang, et al.
Publicado: (2021)